Ocular oncology practice guidelines during COVID-19 pandemic-An expert consensus
Fairooz P Manjandavida1, Santosh G Honavar2, Usha Kim3, Usha Singh4, Vikas Menon5, Sima Das6, Swathi Kaliki7, Mahesh Shanmugam Palanivelu8, Vikas Khetan9, Parag K Shah10, Pukhraj Rishi9, Kaustubh Mulay11, Arpan Gandhi12, BM Vadhiraja13, Vijay Anand Reddy14, Sunil Bhat15, Vasudha Rao16
1 From Ocular Oncology and Oculoplasty Services, Horus Specialty Eye Care, Bangalore, India 2 Ocular Oncology and Oculoplasty Services, Center For Sight, Hyderabad, India 3 Oculoplasty and Ocular Oncology Service, Aravind Eye Care, Madurai, India 4 Advanced Eye Center, Medical Institute- PGIMER, Chandigarh, India 5 Ocular Oncology and Oculoplasty Services, Center For Sight, Delhi, India 6 Ocular Oncology and Oculoplasty Services, Dr. Shroff's Charity Eye Hospital, Delhi, India 7 Operation Eyesight Universal Institute for Eye Cancer, LV Prasad Eye Institute, Hyderabad, India 8 Vitreoretinal Services, Sankara Eye Hospital, Bangalore, India 9 Vitreoretina and Ocular Oncology Services, Sankara Nethralaya, Chennai, India 10 Department of Pediatric Retina and Ocular Oncology, Aravind Eye Hospital, Coimbatore, India 11 National Reporting Center for Ophthalmic Pathology, Center For Sight, Hyderabad, India 12 Ocular Pathology Services, Dr. Shroff's Charity Eye Hospital, Delhi, India 13 Department of Radiation Oncology, Manipal Hospitals, Bangalore, India 14 Medical and Radiation Oncology, Apollo Cancer Institute, Hyderabad, India 15 Pediatric Hematology-Oncology and BMT, Narayana Health City, Bangalore, India 16 Pediatric Oncology, Cytecare Cancer Hospitals, Bangalore, India
Correspondence Address:
Dr. Fairooz P Manjandavida HORUS Specialty Eye Care, Bengaluru, Karnataka India
Source of Support: None, Conflict of Interest: None | Check |
DOI: 10.4103/ijo.IJO_1669_20
|